Mathematical analysis of delay differential equation models of HIV-1 infection

Mathematical Biosciences

Volumn 179, Issue 1, 2002, Pages 73-94

  Nelson, Patrick W ^a   Perelson, Alan S ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

Combination antiviral therapy; Delay differential equations; HIV 1; Stability analysis; T cells

Indexed keywords

CELLS; DIFFERENTIAL EQUATIONS; PARAMETER ESTIMATION; STABILITY;

HIV INFECTIONS;

MATHEMATICAL TECHNIQUES;

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

HUMAN IMMUNODEFICIENCY VIRUS;

ACCURACY; ARTICLE; DATA ANALYSIS; DRUG EFFICACY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS 1; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; NONHUMAN; T LYMPHOCYTE;

ANTIVIRAL AGENTS; HIV INFECTIONS; HIV-1; HUMANS; MODELS, BIOLOGICAL; NUMERICAL ANALYSIS, COMPUTER-ASSISTED; T-LYMPHOCYTES; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036297271     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-5564(02)00099-8     Document Type: Article

References (34)

1. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
2. Viral dynamics in human immunodeficiency virus type 1 infection
3. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
4. Decay characteristics of HIV-1-infected compartments during combination therapy
5. Viral dynamics in vivo: Limitations on estimations on intracellular delay and virus decay
6. HIV infection: How effective is drug combination treatment
7. Ongoing HIV dissemination during HAART
8. Influence of delayed virus production on viral dynamics in HIV-1 infected patients
9. Delay efect in a model for virus replication
10. A Model of HIV-1 pathogenesis that includes an intracellular delay
11. Refined estimates for HIV-1 clearance rate and intracellular delay
12. Effect of drug efficacy and the eclipse phase of the viral life cycle on estimates of HIV-1 viral dynamic parameters
13. Virus dynamics and drug therapy
14. Mathematical considerations of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads
15. Relationship between antiviral treatment effects and biphasic decay rates in modeling HIV dynamics
16. + T cells
17. Ziduvidine and HIV: Mathematical models of within-host population dynamics
18. Using mathematics to understand HIV immune dynamics
19. HIV-1 evolution and disease progression
20. Anti-viral drug treatment: Dynamics of resistance in free virus and infected cell populations
21. Drug concentration heterogeneity facilitates the evolution of drug resistance
22. Mathematical models of HIV dynamics in vivo
23. + T-cells
24. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy
25. Viral dynamics in hepatitis B virus infection
26. Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy
27. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: Evidence for differential gene expression
28. Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells
29. Contribution of multiple rounds of viral entry and reverse transcription to expression of human immunodeficiency virus type 1